ClinicalTrials.Veeva

Menu

Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.

P

Poitiers University Hospital

Status

Unknown

Conditions

The Gold Standard for Current SARS CoV2 Detection is RT-PCR

Treatments

Diagnostic Test: Thoracic CT Scan

Study type

Observational

Funder types

Other

Identifiers

NCT04339686
POWER-COVID_CT

Details and patient eligibility

About

All patients included in this search will be on anonymized file: Symptomatic patients consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner) according to the criteria of the Ministry of Health.

To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID.

CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary.

Ct Scan performance will be recorded and analyzed.

Enrollment

56,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients suspected of COVID 19 consulting for diagnostic

Exclusion criteria

  • Delay between RT-PCR and Thoracic Scan greater than 6 days.

Trial design

56,000 participants in 1 patient group

Suspicion of COVID 19
Treatment:
Diagnostic Test: Thoracic CT Scan

Trial contacts and locations

1

Loading...

Central trial contact

Guillaume HERPE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems